← All stocks

Lexaria Bioscience Corp.

LEXX Net buying
CIK 0001348362 #5058 in the set updated 21 Sep 2026
Bought (120 mo)
$219.40K
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$105.27K
$0.00 on a plan · $0.00 straight out of an exercise
Sold at will
$105.27K
4 of 4 sales
Net
+$114.13K
+$114.13K against sales at will

By person

10 insiders · 34 transactions
Insider
Role
Bought
Sold
Net
Holding
Worth
Change
CHRISTOPHER RICHARD
Chief Executive Officer
$132.03K (3)
+$132.03K
65,000
$59.35K
McKechnie William Edward
Director
$4.53K (1)
$95.00K (3)
−$90.47K
18,191
$16.61K
BUNKA CHRISTOPHER
Director
$67.89K (16)
+$67.89K
7,226,754
$6.60M
+16.7%
Carle Vanessa
Secretary
$682.50 (1)
$10.27K (1)
−$9.59K
750
$684.83
+1,019%
TURKEL CATHERINE C.
Director
$9.27K (2)
+$9.27K
3,100
$2.83K
DOCHERTY JOHN MARTIN
President & CSO
$4.99K (1)
+$4.99K
59,451
$54.28K
Spissinger Allan Horst
Chief Financial Officer
119,116
$108.76K
+333.9%
Baxter Nicholas W
Director
11,000
$10.04K
REESE ALBERT L JR
Director
10,917
$9.97K
+1,091%
Downey Gregory
Chief Financial Officer
1,954
$1.78K
+6.6%

No percentages here. These insiders hold more than one class of share between them, and the share count on file covers one of them rather than all. Dividing the two would compare different things.

Insider
Date
Role
Action
Shares
Price
Amount
BUNKA CHRISTOPHER
30 Jul 2025
Director
Buy indirect
11,900
$0.91
$10.87K
CHRISTOPHER RICHARD
29 Jul 2025
Chief Executive Officer
Buy
15,000
$0.91
$13.64K
Carle Vanessa
29 Jul 2025
Secretary
Buy
750
$0.91
$682.50
DOCHERTY JOHN MARTIN
29 Jul 2025
President & CSO
Buy
5,376
$0.93
$4.99K
McKechnie William Edward
29 Jul 2025
Director
Buy
5,000
$0.91
$4.53K
BUNKA CHRISTOPHER
29 Jul 2025
Director
Buy indirect
15,600
$0.92
$14.38K
CHRISTOPHER RICHARD
3 Dec 2024
Chief Executive Officer
Buy
27,172
$2.47
$67.17K
CHRISTOPHER RICHARD
2 Dec 2024
Chief Executive Officer
Buy
22,828
$2.24
$51.22K
TURKEL CATHERINE C.
12 Aug 2024
Director
Buy
1,600
$3.13
$5.01K
TURKEL CATHERINE C.
9 Feb 2023
Director
Buy
1,500
$2.84
$4.27K
BUNKA CHRISTOPHER
10 Nov 2020
CEO
Buy indirect
25,500
$0.19
$4.80K
BUNKA CHRISTOPHER
10 Nov 2020
CEO
Buy indirect
6,000
$0.20
$1.20K
BUNKA CHRISTOPHER
10 Nov 2020
CEO
Buy indirect
10,000
$0.20
$1.95K
BUNKA CHRISTOPHER
9 Nov 2020
CEO
Buy indirect
22,000
$0.20
$4.39K
BUNKA CHRISTOPHER
9 Nov 2020
CEO
Buy indirect
6,500
$0.20
$1.31K
BUNKA CHRISTOPHER
9 Nov 2020
CEO
Buy indirect
8,000
$0.20
$1.60K
BUNKA CHRISTOPHER
9 Nov 2020
CEO
Buy indirect
10,000
$0.21
$2.13K
BUNKA CHRISTOPHER
9 Nov 2020
CEO
Buy indirect
10,000
$0.20
$2.03K
BUNKA CHRISTOPHER
9 Nov 2020
CEO
Buy indirect
37,500
$0.22
$8.06K
BUNKA CHRISTOPHER
6 Nov 2020
CEO
Buy indirect
60,000
$0.21
$12.31K
BUNKA CHRISTOPHER
7 Oct 2016
CEO
Buy
5,000
$0.12
$600.00
BUNKA CHRISTOPHER
7 Oct 2016
CEO
Buy
5,000
$0.13
$625.00
BUNKA CHRISTOPHER
7 Oct 2016
CEO
Buy
10,000
$0.13
$1.29K
BUNKA CHRISTOPHER
5 Oct 2016
CEO
Buy
2,500
$0.15
$362.50

What was left out

Form 4 filings counted 133
Amendments (4/A) skipped 3
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 0
Sales at will 4
Transactions with no price 0
Shares from compensation/vesting 3,346,455
Sales filed before the plan box existed 3
History held since 6 Oct 2016